All Pharma News
price-trendAsk Us
Menlo Therapeutics Announces Pricing of Offering of Common Stock

Menlo Therapeutics Announces Pricing of Offering of Common Stock
GLOBENEWSWIRE
05 Jun 2020
Share Share
Menlo Therapeutics Announces Positive Results from Phase 2 Trial of FCD105

Menlo Therapeutics Announces Positive Results from Phase 2 Trial of FCD105
GLOBENEWSWIRE
02 Jun 2020
Share Share
Menlo Therapeutics Receives FDA Approval of ZILXI™ (minocycline) topical foam

Menlo Therapeutics Receives FDA Approval of ZILXI™ (minocycline) topical foam
PRNEWSWIRE
29 May 2020
Share Share
Menlo Therapeutics Announces Covered Status for AMZEEQ®

Menlo Therapeutics Announces Covered Status for AMZEEQ®
GLOBENEWSWIRE
27 May 2020
Share Share
Menlo & Cutia Therapeutics Enter into Exclusive License Agreement for AMZEEQ™

Menlo & Cutia Therapeutics Enter into Exclusive License Agreement for AMZEEQ™
GLOBENEWSWIRE
23 Apr 2020
Share Share
Menlo hit with serlopitant setback

Menlo hit with serlopitant setback
Selina McKee PHARMATIMES
07 Apr 2020
Share Share
A pair of PhIII failures spells last rites for Menlo’s once-promising Merck drug

A pair of PhIII failures spells last rites for Menlo’s once-promising Merck drug
Jason Mast ENDPTS
06 Apr 2020
Share Share
Menlo Therapeutics and Foamix Pharmaceuticals Complete Merger

Menlo Therapeutics and Foamix Pharmaceuticals Complete Merger
PR NEWSWIRE
09 Mar 2020
Share Share
Menlo Therapeutics Announces Results from Phase 2 Trial of Serlopitant

Menlo Therapeutics Announces Results from Phase 2 Trial of Serlopitant
GLOBENEWSWIRE
27 Feb 2020
Share Share